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Purpose: The Simplified Acute Physiology Score (SAPS) 3 was recently proposed 
to reflect contemporary changes in intensive care practices. SAPS 3 features cus-
tomized equations for the prediction of mortality in different geographic regions. 
However, the usefulness of SAPS 3 and its customized equation (Australasia SAPS 
3) have never been externally validated in Korea. This study was designed to vali-
date SAPS 3 and Australasia SAPS 3 for mortality prediction in Korea. Materials 
and Methods: A retrospective analysis of the prospective intensive care unit (ICU) 
registry was conducted in the medical ICU of Samsung Medical Center. Calibration 
and discrimination were determined by the Hosmer-Lemeshow test and area under 
the receiver operating characteristic (aROC) curve from 633 patients. Results: The 
mortalities (%) predicted by SAPS 3, Australasia SAPS 3, and SAPS II were 42 ± 
28, 39 ± 27 and 37 ± 31, respectively. The calibration of SAPS II was poor (p = 
0.003). SAPS 3 and Australasia SAPS 3 were appropriate (p > 0.05). The discrimi-
native power of all models yielded aROC values less than 0.8. Conclusion: In Ko-
rea, mortality rates predicted using general SAPS 3 and Australasia SAPS 3 exhibit-
ed good calibration and modest discrimination. However, Australasia SAPS 3 did 
not improve the mortality prediction. To better predict mortality in Korean ICUs, a 
new equation may be needed specifically for Korea. 
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INTRODUCTION
 
Several prognostic scoring systems have been developed to predict hospital mor-
tality in intensive care unit (ICU) patients, the most famous being the Simplified 
Acute Physiology Score (SAPS), the Acute Physiologic and Chronic Health Eval-
uation (APACHE) Score, and the Mortality Prediction Model (MPM). These scores 
can be used as an aid to clinical management, resource allocation, and quality as-
sessment.1,2 However, whether these scoring systems can accurately predict mor-
tality in a modern-day ICU is not known.1-7 So Yeon Lim, et al.
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of each predictive models.1 Expected mortality rates in 10% 
intervals (x-axis) were shown against observed mortality 
rates (y-axis). Discrimination is defined as the power to dis-
tinguish between non-survivors and survivors and was as-
sessed by calculating the area under the receiver operating 
characteristic (aROC) curve.1 A two-tailed p value < 0.05 
was considered statistically significant.
RESULTS
Baseline characteristics of the patients
The baseline characteristics of the patients are reported in 
Table 1. The mean age of the patients was 60 ± 15 years and 
there was a predominance of males (63%). The routes of 
ICU admission were: emergency room [n = 469 (77%)], 
general ward [n = 137 (22%)], and other ICU [n = 27 (1%)]. 
Patients’ characteristics and the main reasons for ICU ad-
mission are outlined in Table 1. The median ICU stay was 5 
days.2-11 
Comparison of predicted mortality
The hospital mortality was 31% (193/633). The SAPS 3 
score was 63 ± 18, while the SAPS II score was 44 ± 20 
points. The predicted mortality rates were 42 ± 28%, 39 ± 
27%, and 37 ± 31% for general SAPS 3, Australasia SAPS 
3, and SAPS II, respectively. 
Calibration of prediction scores
The general SAPS 3 and Australasia SAPS 3 model exhib-
ited good calibration (Ĉ = 3.174, p = 0.923 for general 
SAPS 3, Ĉ = 3.286, p = 0.915 for Australasia SAPS 3) (Ta-
ble 2). The calibration of SAPS II was poor (Ĉ = 23.470, p 
= 0.003) (Table 2). The Australasia SAPS 3 model did not 
improve the uniformity of fit of the general SAPS 3 model 
(Fig. 1).
Comparison of discrimination
Although general SAPS 3 and Australasia SAPS 3 had a 
greater aROC, suggesting slightly better discriminative 
power than the SAPS II model, all predicted models had 
aROC values less than 0.8. Customization using the Aus-
tralasia equation did not improve the discriminative ability 
of the original score and the SAPS II score had the lowest 
aROC [aROC 0.76, 95% confidence interval (CI) 0.73, 
0.80] (Table 2). We did not detect any improvement in dis-
criminative power by using the Australasia equation in our 
Recently, SAPS 3 was developed through a worldwide 
prospective study. SAPS 3 features customized prognostic 
models for different geographic regions. However, to our 
knowledge, there have been no external validations of 
SAPS 3 or its Australasia prognostic model in a critical care 
population of Korea.6 This study was designed to assess the 
validity of general SAPS 3 admission score and its Austral-
asia prognostic model in a Korean intensive care sample. 
MATERIALS AND METHODS
Patients
All patients admitted to the medical ICU of Samsung Med-
ical Center, a 1,900-bed tertiary referral center in Seoul, 
South Korea, between March 1st, 2008 and February 28st, 
2009, were eligible for this study. We excluded patients if 
they were less than 15 years old, or stayed in the ICU < 8 h. 
For patients with two or more admissions to the ICU during 
the same hospital stay, only the data from the first admis-
sion were included. A total of 660 patients were admitted to 
our medical ICU, and a total of 633 patients were included 
in the study. The study was approved by the Institutional 
Review Board and the requirement for informed consent 
was waived.
Data collection  
We drew data from a prospectively collected database. We 
used the worst data from the first 24 hours after admission 
to the ICU to calculate the SAPS II score, while data from 
the first hour after admission were used to calculate the 
SAPS 3 score. For the SAPS 3 score, data were recorded 
using a SAPS 3 admission score sheet downloaded from 
the SAPS 3 website (http://www.saps3.org). The predicted 
mortality was also estimated using the customized equation 
for Australasia.1,8 The customized SAPS 3 score equation 
for Australasia is as follows: Logit = - 22.5717 + ln (SAPS 
3 score + 1) × 5.3163.1 There were no missing data.
Statistical analysis
Data are shown as mean ± standard deviation (SD). For sta-
tistical analysis, SAS 9.1 was used (SAS Institute Inc., Cary, 
NC, USA). Validation of the scoring system was performed 
using standard tests to measure calibration and discrimina-
tion. Calibration is defined as the agreement between indi-
vidual probabilities and actual outcomes. The Hosmer-
Lemeshow goodness of fit Ĉ statistic to evaluate calibration Validation of the SAPS 3 in a Korean ICU
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rates. Second, SAPS 3 reflects the chronic health status and 
the conditions before admission to ICU which can influ-
ence long-term prognosis of these patients.2 Finally, SAPS 
3 features customized equations that were developed to 
consider regional differences in disease distributions, genet-
ic factors, and therapeutic behaviors.
To our knowledge, this is the first study exploring the 
validation of general SAPS 3 or its customized equation for 
Australasia in patients of Korea. External validation is es-
sential before routine application of any model in a group 
of patients different from the one originally used for model 
development. So far there have been only a handful of stud-
ies of the external validation of SAPS 3 and its customized 
scores, with mixed results. In an external validation study 
of a general intensive care population in Europe, SAPS 3 
and its customized model for Central and Western Europe 
were more discriminative and had better calibration com-
pared to Acute Physiology and Chronic Health Evaluation 
II (APACHE II), but were not significantly better than 
SAPS II.9 An Austrian validation study found that the SAPS 
3 admission score overestimated hospital mortality but that 
the customized equation showed excellent calibration and 
discrimination.1 Validation of the SAPS 3 score in Brazil, 
and, in particular, its customized equation for Central and 
South American countries, was successful in critically ill 
sample of Korean intensive care patients (Table 2). 
DISCUSSION
SAPS II is one of the most commonly used prognostic 
scoring systems in critically ill patients, but a revised scor-
ing system, SAPS 3, was devised for several reasons. First, 
the SAPS II score was developed from a database collected 
in the early 1990s, and there have been significant changes 
in the prevalence of major diseases, diagnostic approaches, 
and therapeutic modalities since that time.1-3 Second, previ-
ous prognostic models did not take into account the clinical 
milieus of different regions of the world, being developed 
mostly from clinical data of European and North American 
origin.1,2 Third, many reports suggested that SAPS II has 
poor predictive power in different populations, limiting its 
usefulness.7 
The SAPS 3 scoring system was developed to enhance 
prediction power by overcoming these deficiencies. The 
SAPS 3 has the following unique characteristics. First, 
SAPS 3 is composed of 20 variables gathered within one 
hour of ICU admission.2 So SAPS 3 is not affected by the 
Boyd and Grounds effect,2 thus in theoy it should have re-
duced risk of overestimated prediction about the mortality 
Table 1. Baseline Clinical Profiles of the Patients 
Variables Characteristics %
Number of patients 633
Age, yrs (mean ± SD) 60 ± 15
Gender, male : female 401 : 232 63 : 37
Admission route, ER : ward : other ICU 469 : 137 : 27 77 : 22 : 1
Reason for admission
　Hemato-oncology 157 25
　Respiratory 162 26
　Gastrointestinal   57   9
　Cardiovascular 167 26
    Other   90 14
ICU length of stay (days), median     5
    25 - 75% inter-quartile range 2 - 11 
Observed hospital mortality 193 31
SAPS 3 score (mean ± SD) 63 ± 18
　Predicted death rate 42 ± 28
Australasia SAPS 3, predicted death rate 39 ± 27
SAPS II score (mean ± SD) 44 ± 20
    Predicted death rate 37 ± 31
SD, standard deviation; ER, emergency room; ICU, intensive care unit; SAPS, simplified acute physiology score.
Patients’ characteristics and the main reasons for ICU admission are outlined.So Yeon Lim, et al.
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Table 2. Hosmer-Lemeshow Goodness of fit Ĉ Test and Area under the Receiver-Operating Characteristic Curves 
   Prediction models
Score
(mean ± SD)
Predicted mortality
(%, mean ± SD)
Goodness-of fit Ĉ test ROC curve
aROC ± SE (95% CI) Ĉ p value
General SAPS 3 63 ± 18 42 ± 28   3.174 0.923 0.78 ± 0.02 (0.75, 0.81)
Australasia SAPS 3 - 39 ± 27   3.286 0.915 0.78 ± 0.02 (0.75, 0.81)
SAPS II 44 ± 20 37 ± 31 23.470 0.003 0.76 ± 0.02 (0.73, 0.80)
SD, standard deviation; ROC, receiver operating characteristic; aROC, area under the receiver operating characteristic; SE, standard error; 95% CI, 95% 
confidence interval; SAPS, simplified acute physiology score.
The general SAPS 3 and Australasia SAPS 3 model exhibited good calibration (Ĉ = 3.174, p = 0.923 for general SAPS 3, Ĉ = 3.286, p = 0.915 for Austral-
asia SAPS 3). The calibration of SAPS II was poor (Ĉ = 23.470, p = 0.003). Customization using the Australasia equation did not improve the discriminative 
ability of the original score and the SAPS II score had the lowest aROC (aROC 0.76, 95% CI 0.73, 0.80).
Fig. 1. Calibration curves for the general SAPS 3, Australasia SAPS 3, and SAPS II. Predicted risk of hospital death, observed hospital 
mortality rate, and the corresponding number of patients per decile are shown. Columns; number of patients; line with open circles; mean 
predicted mortality per decile; line with closed circles; mean observed mortality per decile.
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samples. In the original cohort of SAPS 3, the median SAPS 
II score was 28, and ICU mortality was 12.7%, which is 
significantly different from our cohort (SAPS II mean of 
44). In addition, 25% of our cohort was made up of cancer 
patients, while in the original SAPS 3 cohort this fraction 
was only 10%. Finally, different patterns and quality of ICU 
care might have resulted in these discrepancies. However, 
our observed mortality was similar with the predicted mor-
tality from all three scores, which suggests that the results 
of this study did not result from poor intensive care quality.
Our study has several limitations. It is a retrospective anal-
ysis of prospectively collected data, but we made every effort 
to validate the data as thoroughly as possible. Second, the 
data are from a single center with a relatively limited number 
of patients, which limits the generalization of our findings.
In conclusion, the SAPS 3 admission prognostic model 
had good calibration and modest discriminative power 
when applied to ICU patients in Korea. However, its cus-
tomized equation for Australasia did not improve predictive 
power. Therefore, a new prognostic model customized for 
Korean patients is deemed necessary.
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